Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2021-03-23 AGM Information
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Notice of General Meeting' (주주총회소집공고). It contains detailed financial statements (Consolidated and Separate Statements of Financial Position, Comprehensive Income, Changes in Equity, and Cash Flows) for the fiscal year 2020, which were updated due to audit results. Since this document is a formal regulatory filing providing corrected financial information for a shareholder meeting, it falls under the category of regulatory filings that provide financial data and governance updates.
2021-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from the company 'Notus'. It provides a summary table of financial data (assets, liabilities, equity, revenue, operating profit) and the auditor's opinion (unqualified/proper). While it contains financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report, rather than the full annual report document itself. According to the 'Menu vs Meal' rule, this is a notification of a report's availability/submission, which falls under the Report Publication Announcement (RPA) category. FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'Notus' (주식회사 노터스) for the fiscal year ending December 31, 2020. It includes the independent auditor's report, financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes to the financial statements. While it contains financial data, it is not a standalone 'Annual Report' (10-K) which typically includes management discussion and analysis (MD&A) and business overview sections, nor is it a simple 'Earnings Release'. It is a formal audit report document. FY 2020
2021-03-22 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Knotus Co., Ltd. It contains the agenda for the 9th Annual General Meeting, including the approval of financial statements, election of directors, and amendments to the articles of incorporation. It also includes detailed financial statements (balance sheet, income statement, statement of changes in equity) as part of the meeting materials. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the meeting and request their votes.
2021-03-15 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company 'Notus'. It details the date, location, and specific agenda items such as financial statement approval, board member appointments, and business purpose changes. This document is a standard proxy solicitation material provided to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement.
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted by the company 'Notus' regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date when many companies hold their AGMs). It explains the rationale for choosing March 30, 2021, and acknowledges the company's participation status in the KOSDAQ Association's voluntary compliance program for dispersing shareholder meetings. As this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a voting result, it falls under the general regulatory filing category.
2021-03-15 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.